Construction of a Nano-Controlled Release Methotrexate Delivery System for the Treatment of Rheumatoid Arthritis by Local Percutaneous Administration
A drug delivery system was specifically designed for the treatment of rheumatoid arthritis (RA) by local percutaneous administration and the nano-controlled release of methotrexate (MTX). The release behavior of MTX from the synthesized MTX-mSiO<sub>2</sub>@PDA system was investigated in...
Guardado en:
Autores principales: | Tingting Guo, Xu Kang, Sifan Ren, Xianjin Ouyang, Mingming Chang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6fcdfd0277584f1dad57dd24216c4a7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis
por: Zhao J, et al.
Publicado: (2017) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
por: Almalag H, et al.
Publicado: (2020) -
Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
por: Karel Hloch, et al.
Publicado: (2021) -
Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
por: Ivan Padjen, et al.
Publicado: (2020) -
DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
por: E. S. Zhugrova, et al.
Publicado: (2014)